Evidence map›Paper›PMID 33583673›Full record

ReviewVaccine2021

Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Nathan A Serazin, Bassey Edem, Sarah R Williams, Justin R Ortiz, Anand Kawade, Manoj Kumar Das, Maja Šubelj, Kathryn M Edwards, Shreemanta K Parida, T Anh Wartel and 2 more

Abstract readReview
In one paragraph

Review in Vaccine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nathan A SerazinDepartment of Pediatrics, Section of Critical Care Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Bassey EdemDepartment of Vaccines and Immunity, Medical Research Council the Gambia Unit at the London School of Hygiene and Tropical Medicine, UK.
Sarah R WilliamsDivision of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
Justin R OrtizCenter for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Anand KawadeKing Edward Memorial Hospital Research Centre, Vadu Rural Health Program Pune, India.
Manoj Kumar DasThe INCLEN Trust International, New Delhi, India.
Maja ŠubeljNational Institute of Public Health, University of Ljubljana, Slovenia.
Kathryn M EdwardsDivision of Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
Shreemanta K ParidaCureVac AG, Frankfurt, Germany.
T Anh WartelInternational Vaccine Institute, Seoul, Republic of Korea.
Flor M MunozDepartments of Pediatrics, Section of Infectious Diseases, and Molecular Virology and Microbiology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Patricia BasteroDepartment of Pediatrics, Section of Critical Care Medicine, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA. Electronic address: pxbaster@texaschildrens.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is a Brighton Collaboration Case Definition of the term "Acute Respiratory Distress Syndrome - ARDS" to be utilized in the evaluation of adverse events following immunization. The Case Definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for SARS-CoV-2 vaccines and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and defined levels of certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network and by selected Expert Reviewers prior to submission. The comments of the reviewers were taken into consideration and edits incorporated in this final manuscript.

Indexed as

COVID-19Respiratory Distress SyndromeCOVID-19 VaccinesData CollectionHumansImmunizationSARS-CoV-2COVID-19 VaccinesAcute respiratory distress syndromeAdultAdverse eventARDSCase definitionCOVID-19GuidelinesImmunizationPediatric

Identifiers

PMID33583673
PMCPMC7843093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.